Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics inMycobacterium smegmatisby perturbation of the drug binding pocket-Reference-Cited by-同舟云学术

Single 23S rRNA mutations at the ribosomal peptidyl transferase centre confer resistance to valnemulin and other antibiotics inMycobacterium smegmatisby perturbation of the drug binding pocket

Published:2009-03 Issue:5 Volume:71 Page:1218-1227
ISSN:0950-382X
Container-title:Molecular Microbiology
language:en
Short-container-title:

Author:

Long Katherine S.,Poehlsgaard Jacob,Hansen Lykke H.,Hobbie Sven N.,Böttger Erik C.,Vester Birte

Publisher

Wiley

Subject

Molecular Biology,Microbiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2958.2009.06596.x/fullpdf

Reference46 articles.

1. Mutations outside the anisomycin-binding site can make ribosomes drug-resistant;Blaha;J Mol Biol,2008

2. Resistance to the peptidyl transferase inhibitor tiamulin caused by mutation of ribosomal protein L3;Bøsling;Antimicrob Agents Chemother,2003

3. Induced-fit tightens pleuromutilins binding to ribosomes and remote interactions enable their selectivity;Davidovich;Proc Natl Acad Sci USA,2007

4. Probing the structure of RNAs in solution;Ehresmann;Nucleic Acids Res,1987

5. In vitro development of resistance to enrofloxacin, erythromycin, tylosin, tiamulin and oxytetracycline in Mycoplasma gallisepticum, Mycoplasma iowae and Mycoplasma synoviae;Gautier-Bouchardon;Vet Microbiol,2002

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, in vitro and in vivo evaluation and molecular docking study of novel pleuromutilin derivatives as antibacterial agents;Fitoterapia;2024-07

2. Characterization and In vivo Evaluation of Polymorphic Valnemulin Hydrogen Fumarate;Current Drug Delivery;2024-06-05

3. Design, synthesis, and antibacterial activity of pleuromutilin derivatives;Chemical Biology & Drug Design;2024-05-28

4. Scientific Rationale and Clinical Basis for Clindamycin Use in the Treatment of Dermatologic Disease;Antibiotics;2024-03-17

5. Synthesis and Biological Activities of Oxazolidinone Pleuromutilin Derivatives as a Potent Anti-MRSA Agent;ACS Infectious Diseases;2023-08-23